A Chimeric Peptide of Intestinal Trefoil Factor Containing Cholesteryl Ester Transfer Protein B Cell Epitope Significantly Inhibits Atherosclerosis in Rabbits after Oral Administration.

Gaofu Qi,Jingjing Li,Shengying Wang,Shanshan Xin,Peng Du,Qingye Zhang,Xiuyun Zhao
DOI: https://doi.org/10.1016/j.peptides.2010.12.014
IF: 3.867
2010-01-01
Peptides
Abstract:Vaccination against cholesteryl ester transfer protein (CETP) is proven to be effective for inhibiting atherosclerosis in animal models. In this study, the proteases-resistant intestinal trefoil factor (TFF3) was used as a molecular vehicle to construct chimeric TFF3 (cTFF3) containing CETP B cell epitope and tetanus toxin helper T cell epitope. It was found that cTFF3 still preserved a trefoil structure, and can resist proteases digestion in vitro. After oral immunization with cTFF3, the CETP-specific IgA and IgG could be found in intestine lavage fluid and serum, and the anti-CETP antibodies could inhibit partial CETP activity to increase high-density lipoprotein cholesterol, decrease low-density lipoprotein cholesterol, and inhibit atherosclerosis in animals. Therefore, TFF3 is a potential molecular vehicle for developing oral peptide vaccines. Our research highlights a novel strategy for developing oral peptide vaccines in the future.
What problem does this paper attempt to address?